These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18635905)

  • 1. Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.
    Maeba R; Hara H; Ishikawa H; Hayashi S; Yoshimura N; Kusano J; Takeoka Y; Yasuda D; Okazaki T; Kinoshita M; Teramoto T
    J Nutr Sci Vitaminol (Tokyo); 2008 Jun; 54(3):196-202. PubMed ID: 18635905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proportion of nervonic acid in serum lipids is associated with serum plasmalogen levels and metabolic syndrome.
    Yamazaki Y; Kondo K; Maeba R; Nishimukai M; Nezu T; Hara H
    J Oleo Sci; 2014; 63(5):527-37. PubMed ID: 24770479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmalogens in human serum positively correlate with high- density lipoprotein and decrease with aging.
    Maeba R; Maeda T; Kinoshita M; Takao K; Takenaka H; Kusano J; Yoshimura N; Takeoka Y; Yasuda D; Okazaki T; Teramoto T
    J Atheroscler Thromb; 2007 Feb; 14(1):12-8. PubMed ID: 17332687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between circulating oxidized-LDL and metabolic syndrome in children with obesity: the role of hypertriglyceridemic waist phenotype.
    Calcaterra V; De Giuseppe R; Biino G; Mantelli M; Marchini S; Bendotti G; Madè A; Avanzini MA; Montalbano C; Cossellu G; Larizza D; Cena H
    J Pediatr Endocrinol Metab; 2017 Nov; 30(12):1257-1263. PubMed ID: 29127769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome.
    Santamaria A; Giordano D; Corrado F; Pintaudi B; Interdonato ML; Vieste GD; Benedetto AD; D'Anna R
    Climacteric; 2012 Oct; 15(5):490-5. PubMed ID: 22192068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers.
    Maeba R; Araki A; Fujiwara Y
    Adv Clin Chem; 2018; 87():69-111. PubMed ID: 30342713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes.
    Antonowski T; Osowski A; Lahuta L; Górecki R; Rynkiewicz A; Wojtkiewicz J
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31574903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
    Pontrelli L; Parris W; Adeli K; Cheung RC
    Metabolism; 2002 Mar; 51(3):334-42. PubMed ID: 11887170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridemia is a major factor associated with elevated levels of small dense LDL cholesterol in patients with metabolic syndrome.
    Cho Y; Lee SG; Jee SH; Kim JH
    Ann Lab Med; 2015 Nov; 35(6):586-94. PubMed ID: 26354346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women.
    Schmitt EB; Nahas-Neto J; Bueloni-Dias F; Poloni PF; Orsatti CL; Petri Nahas EA
    Maturitas; 2018 Jan; 107():97-102. PubMed ID: 29169589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.
    Galletti F; Fazio V; Gentile M; Schillaci G; Pucci G; Battista F; Mercurio V; Bosso G; Bonaduce D; Brambilla N; Vitalini C; D'Amato M; Giacovelli G
    Lipids Health Dis; 2019 Mar; 18(1):66. PubMed ID: 30885221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism.
    Stechemesser L; Eder SK; Wagner A; Patsch W; Feldman A; Strasser M; Auer S; Niederseer D; Huber-Schönauer U; Paulweber B; Zandanell S; Ruhaltinger S; Weghuber D; Haschke-Becher E; Grabmer C; Rohde E; Datz C; Felder TK; Aigner E
    Mol Metab; 2017 Jan; 6(1):38-47. PubMed ID: 28123936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in High Sensitivity C-Reactive Protein in Subjects with Risk Factors of Metabolic Syndrome.
    Garcia VP; Rocha HN; Sales AR; Rocha NG; da Nóbrega AC
    Arq Bras Cardiol; 2016 Mar; 106(3):182-7. PubMed ID: 27027366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cholesterol efflux capacity with plasmalogen levels of high-density lipoprotein: A cross-sectional study in chronic kidney disease patients.
    Maeba R; Kojima KI; Nagura M; Komori A; Nishimukai M; Okazaki T; Uchida S
    Atherosclerosis; 2018 Mar; 270():102-109. PubMed ID: 29407877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hypertension with small, dense low-density lipoprotein in patients without metabolic syndrome.
    Kim YK; Seo HS; Lee EM; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    J Hum Hypertens; 2012 Nov; 26(11):670-6. PubMed ID: 21975689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation.
    Fan J; Liu Y; Yin S; Chen N; Bai X; Ke Q; Shen J; Xia M
    Nutr Metab (Lond); 2019; 16():7. PubMed ID: 30679939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
    Costantino D; Minozzi G; Minozzi E; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2009; 13(2):105-10. PubMed ID: 19499845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of Biochemical Parameters with Flow-mediated Dilatation in Patients with Metabolic Syndrome.
    Sipahioglu NT; Ilerigelen B; Gungor ZB; Ayaz G; Ekmekci H; Gurel CB; Can G; Sonmez H; Ulutin T; Sipahioglu F
    Chin Med J (Engl); 2017 Jul; 130(13):1564-1569. PubMed ID: 28639572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of myo-inositol and plasmalogen metabolism in rat brain.
    Hoffman-Kuczynski B; Reo NV
    Neurochem Res; 2004 Apr; 29(4):843-55. PubMed ID: 15098950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.